A detailed history of North Crest Asset Manangement, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 64,291 shares of ABT stock, worth $7.53 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
64,291
Previous 63,819 0.74%
Holding current value
$7.53 Million
Previous $6.63 Million 10.53%
% of portfolio
0.23%
Previous 0.23%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$100.07 - $118.13 $47,233 - $55,757
472 Added 0.74%
64,291 $7.33 Million
Q2 2024

Jul 16, 2024

BUY
$100.73 - $112.44 $95,089 - $106,143
944 Added 1.5%
63,819 $6.63 Million
Q1 2024

Apr 15, 2024

BUY
$109.52 - $120.96 $31,541 - $34,836
288 Added 0.46%
62,875 $7.15 Million
Q4 2023

Jan 30, 2024

SELL
$90.19 - $110.4 $77,653 - $95,054
-861 Reduced 1.36%
62,587 $6.89 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $23,213 - $27,852
-243 Reduced 0.38%
63,448 $6.14 Million
Q2 2023

Jul 21, 2023

BUY
$100.78 - $112.29 $81,027 - $90,281
804 Added 1.28%
63,691 $6.94 Million
Q1 2023

Apr 25, 2023

BUY
$96.86 - $114.01 $1.4 Million - $1.64 Million
14,423 Added 29.76%
62,887 $6.37 Million
Q4 2022

Feb 01, 2023

SELL
$95.06 - $111.52 $1.07 Million - $1.26 Million
-11,270 Reduced 18.87%
48,464 $5.32 Million
Q3 2022

Oct 17, 2022

BUY
$96.76 - $112.03 $42,380 - $49,069
438 Added 0.74%
59,734 $5.78 Million
Q2 2022

Jul 18, 2022

BUY
$102.07 - $123.37 $1.61 Million - $1.95 Million
15,789 Added 36.29%
59,296 $6.44 Million
Q1 2022

Apr 18, 2022

SELL
$114.02 - $139.04 $1.57 Million - $1.92 Million
-13,803 Reduced 24.08%
43,507 $5.15 Million
Q4 2021

Feb 09, 2022

BUY
$115.53 - $141.46 $6.62 Million - $8.11 Million
57,310 New
57,310 $8.07 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track North Crest Asset Manangement, LLC Portfolio

Follow North Crest Asset Manangement, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Crest Asset Manangement, LLC with notifications on news.